JP4840298B2 - Chitosan combination beverage - Google Patents

Chitosan combination beverage Download PDF

Info

Publication number
JP4840298B2
JP4840298B2 JP2007228408A JP2007228408A JP4840298B2 JP 4840298 B2 JP4840298 B2 JP 4840298B2 JP 2007228408 A JP2007228408 A JP 2007228408A JP 2007228408 A JP2007228408 A JP 2007228408A JP 4840298 B2 JP4840298 B2 JP 4840298B2
Authority
JP
Japan
Prior art keywords
chitosan
water
chondroitin sulfate
beverage
astringency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2007228408A
Other languages
Japanese (ja)
Other versions
JP2009055882A (en
Inventor
隆史 堂本
拓人 武井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2007228408A priority Critical patent/JP4840298B2/en
Publication of JP2009055882A publication Critical patent/JP2009055882A/en
Application granted granted Critical
Publication of JP4840298B2 publication Critical patent/JP4840298B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、キトサン、及びコンドロイチン硫酸又はその塩を配合した飲料に関し、医薬品、医薬部外品及び食品の分野に応用することができる。   The present invention relates to a beverage containing chitosan and chondroitin sulfate or a salt thereof, and can be applied to the fields of pharmaceuticals, quasi drugs and foods.

キトサンは機能性食物繊維の一種であり、一般的にカニ、エビ、オキアミ等の甲殻類の甲皮、カブトムシ、バッタ等の昆虫類の甲皮、イカの骨等を脱カルシウム処理し、除タンパク質処理して得られるキチンを脱アセチル化処理することで製造される。キトサンは、脂質の消化吸収を阻害する効果(特許文献1参照)、血清コレステロール濃度上昇抑制効果(非特許文献1参照)、血清尿酸値上昇抑制効果や血清尿酸値改善効果等(特許文献2参照)を有することが知られている。またこの他にも、キトサンは抗菌性、創傷治癒作用、凝集性、保湿性等において優れた作用を有する。このため、キトサンを含む製品が開発されているが、キトサンは中性付近では水に溶解しにくく、酸性で溶解させてpHを中性付近に戻す方法でも、キトサン特有の渋味が生じるため飲料にはあまり適していなかった。   Chitosan is a kind of functional dietary fiber, and generally decalcifies crustacean crusts such as crabs, shrimps and krill, insect crusts such as beetles and grasshoppers, squid bones, etc. It is manufactured by deacetylating the chitin obtained by the treatment. Chitosan has an effect of inhibiting digestion and absorption of lipids (see Patent Document 1), an effect of suppressing an increase in serum cholesterol concentration (see Non-Patent Document 1), an effect of suppressing an increase in serum uric acid level, an effect of improving serum uric acid level, etc. (see Patent Document 2) ). In addition to this, chitosan has an excellent action in antibacterial properties, wound healing action, cohesiveness, moisture retention and the like. For this reason, a product containing chitosan has been developed. However, chitosan is difficult to dissolve in water near neutrality, and even when the pH is returned to near neutrality by dissolving it in an acidic state, the astringency peculiar to chitosan is produced. It was not very suitable for.

また、キトサンを低分子化(分子量1万以下)した水溶性キトサンは酸性だけでなく中性でも容易に水に溶解することが知られている。水溶性キトサンは、低分子となっても優れた生理作用をもち、免疫賦活効果、肝機能改善効果,血糖値低下効果等が報告されている(非特許文献2参照)。しかし、水溶性キトサンもキトサン特有の渋味を有しており、この渋みは飲料としての継続的な摂取の障害となっている。
そこで、キトサン及び水溶性キトサンを含む製品の風味改善方法として、ゼインのマトリックスでキトサン及び水溶性キトサンを固定化する方法(特許文献3参照)、アルギン酸塩を配合する方法(特許文献4参照)等が報告されているが、前者は固形物であり、後者は溶液の粘度が非常に高くなるため飲料を提供する際には適さない。
In addition, it is known that water-soluble chitosan obtained by lowering the molecular weight of chitosan (molecular weight of 10,000 or less) easily dissolves in water, not only acidic but also neutral. Water-soluble chitosan has an excellent physiological function even when it is a low molecule, and has been reported to have an immunostimulatory effect, a liver function improving effect, a blood glucose level reducing effect, and the like (see Non-Patent Document 2). However, water-soluble chitosan also has an astringency peculiar to chitosan, and this astringency is an obstacle to continuous intake as a beverage.
Therefore, as a method for improving the flavor of a product containing chitosan and water-soluble chitosan, a method of immobilizing chitosan and water-soluble chitosan with a zein matrix (see Patent Document 3), a method of blending alginate (see Patent Document 4), etc. However, the former is a solid, and the latter is not suitable for providing a beverage because the viscosity of the solution becomes very high.

一方、コンドロイチン硫酸は動物の軟骨に多く存在する物質であり、注射液剤として腰痛症、関節痛、肩関節周囲炎(五十肩)等の治療 点眼液で角膜表層の保護等に用いられている。この様に、コンドロイチン硫酸は無色または白色の結晶粉末で臭いも味もなく、生理活性物質として利用されている。塩基性薬物の苦味や痺れ感を抑制する報告(特許文献5参照)はあるが、渋味に対するマスキング効果の報告は無い。   On the other hand, chondroitin sulfate is a substance that is abundant in cartilage of animals and is used as an injectable solution for the treatment of the corneal surface layer with ophthalmic solutions such as low back pain, joint pain, and shoulder periarthritis (fifty shoulders). In this way, chondroitin sulfate is a colorless or white crystal powder that does not smell or taste and is used as a physiologically active substance. There are reports (see Patent Document 5) that suppress the bitterness and numbness of basic drugs, but there is no report of the masking effect on astringency.

特許第2667351号公報Japanese Patent No. 2667351 特開2001−163788号公報JP 2001-163788 A 特開2003−104899号公報JP 2003-104899 A 特開2000−270809号公報JP 2000-270809 A 特開2005−41887号公報JP 2005-41887 A 前崎ら、1998年、FOOD Style 21、67−71Maezaki et al., 1998, FOOD Style 21, 67-71 川口光朗、1998年、応用糖質化学 45 4 415−419Mitsuo Kawaguchi, 1998, Applied carbohydrate chemistry 45 4 415-419

本発明は、キトサンに起因する渋みを抑制し、飲料としての粘性に問題の無い、日常的に無理なく摂取可能な服用性の良いキトサン配合飲料を提供することを目的とする。   An object of the present invention is to provide a chitosan-containing beverage with good dosing that can be taken on a daily basis without any problem of viscosity as a beverage, suppressing astringency caused by chitosan.

本発明者らは、上記課題を解決するために鋭意検討した結果、キトサン溶液に、コンドロイチン硫酸又はその塩を配合することにより、キトサンが溶解した際に生じる渋味が改善され、飲料としての粘性も適当な、服用し易いキトサン配合飲料が得られることを見いだし、本発明を完成した。   As a result of diligent studies to solve the above problems, the present inventors have improved the astringency that occurs when chitosan is dissolved by adding chondroitin sulfate or a salt thereof to the chitosan solution, and the viscosity as a beverage. In addition, the present inventors have found that a suitable and easy-to-take chitosan-containing beverage can be obtained, and the present invention has been completed.

すなわち、本発明はキトサン、及びコンドロイチン硫酸又はその塩を配合することを特徴とする飲料である。   That is, the present invention is a beverage characterized by containing chitosan and chondroitin sulfate or a salt thereof.

本発明の他の態様としては、キトサンが、水溶性キトサンである前記飲料であり、また、他の態様としては、前記水溶性キトサンが、キトサンオリゴ糖である前記飲料である。   In another aspect of the present invention, the beverage is chitosan, which is water-soluble chitosan. In another embodiment, the water-soluble chitosan is chitosan oligosaccharide.

本発明により、キトサンに起因する渋味が改善され、且つ極めて服用しやすいキトサン配合飲料を提供することが可能となった。   According to the present invention, it has become possible to provide a chitosan-containing beverage that has improved astringency caused by chitosan and is extremely easy to take.

本発明におけるキトサンとは、β−1,4-ポリ-D-グルコサミンを示し、エビ、カニをはじめとして、昆虫、貝、キノコなどから得られるキチンをアルカリ処理することによって得られる。   Chitosan in the present invention refers to β-1,4-poly-D-glucosamine, and is obtained by alkali treatment of chitin obtained from shrimp, crab, insects, shellfish, mushrooms and the like.

本発明における水溶性キトサンとは、分子量が1万以下のキトサンを示し、製造方法等の違いにより分子量や分子量分布の異なる種々の水溶性キトサンが得られるが、本発明における水溶性キトサンとは、これらすべてを含む。一部の水溶性キトサンは、キトサンに分離膜工法(米国特許第5730876号参照)を適用することによって得ることができる。また、水溶性キトサンの1種であるキトサンオリゴ糖は、キトサンを塩酸或いは酵素により直接加水分解(特開昭61−21102号又は特開昭61−21103号参照)を行うことにより得ることができる。キトサンオリゴ糖はキトサン分解物、オリゴグルコサミン、グルコサミンオリゴマーとも呼ばれ、グルコサミンが2〜10個程度つながった構造である。また、本発明における水溶性キトサンとは、渋味を有する水溶性キトサンを含んでいる限り、水溶性キトサンの精製の度合いに制限はなく、未精製品あるいは部分精製品も含まれる。   The water-soluble chitosan in the present invention refers to chitosan having a molecular weight of 10,000 or less, and various water-soluble chitosans having different molecular weights and molecular weight distributions can be obtained due to differences in production methods and the like. Including all of these. Some water-soluble chitosan can be obtained by applying a separation membrane method (see US Pat. No. 5,730,766) to chitosan. In addition, chitosan oligosaccharide, which is a kind of water-soluble chitosan, can be obtained by directly hydrolyzing chitosan with hydrochloric acid or an enzyme (see Japanese Patent Laid-Open Nos. 61-211102 and 61-21103). . Chitosan oligosaccharide is also called chitosan degradation product, oligoglucosamine, or glucosamine oligomer, and has a structure in which about 2 to 10 glucosamines are connected. In addition, the water-soluble chitosan in the present invention is not limited in the degree of purification of the water-soluble chitosan as long as it contains water-soluble chitosan having astringency, and includes unrefined products or partially purified products.

本発明におけるコンドロイチン硫酸とは、ムコ多糖の一種で、D-グルクロン酸とN−アセチル−D−ガラクトサミンを主要繰り返し単位とする化合物を示し、例えば、硫酸基の置換位置により、コンドロイチン4硫酸(コンドロイチン硫酸Aとも呼ばれる)、コンドロイチン硫酸6硫酸(コンドロイチン硫酸Cとも呼ばれる)が挙げられ、硫酸基の置換位置が異なるコンドロイチン硫酸の混合物も含む。コンドロイチン硫酸を製造する方法としては化学合成の他に、サメ、鮭、イカ若しくはウシ等の動植物の骨、軟骨又は皮等の原料から抽出する方法が知られており、本発明においては、化学合成品の他にこれら抽出物も利用することができる。コンドロイチン硫酸の塩としては、例えば、コンドロイチン硫酸ナトリウムが挙げられる。コンドロイチン硫酸又はその塩の配合量は、キトサン又は水溶性キトサン1質量部に対して0.1〜30質量部であり、好ましくは1〜20質量部である。この配合量により、キトサン又は水溶性キトサンが呈する強い渋味を無味無臭のコンドロイチン硫酸又はその塩が効果的に低減することができる。   The chondroitin sulfate in the present invention is a kind of mucopolysaccharide, and indicates a compound having D-glucuronic acid and N-acetyl-D-galactosamine as main repeating units. For example, chondroitin 4 sulfate (chondroitin) is selected depending on the substitution position of the sulfate group. (Also referred to as sulfate A), chondroitin sulfate 6-sulfate (also referred to as chondroitin sulfate C), and a mixture of chondroitin sulfates having different sulfate group substitution positions is also included. As a method of producing chondroitin sulfate, in addition to chemical synthesis, a method of extracting from raw materials such as bone, cartilage, or skin of animals and plants such as shark, shark, squid or cow is known. In addition to products, these extracts can also be used. Examples of the chondroitin sulfate salt include sodium chondroitin sulfate. The compounding quantity of chondroitin sulfate or its salt is 0.1-30 mass parts with respect to 1 mass part of chitosan or water-soluble chitosan, Preferably it is 1-20 mass parts. By this blending amount, the strong astringency exhibited by chitosan or water-soluble chitosan can be effectively reduced by tasteless and odorless chondroitin sulfate or a salt thereof.

本発明における飲料のpHは、キトサンを用いる場合には、2.0〜7.0であり、より好ましくは2.5〜6.5である。水溶性キトサンを用いる場合には、特に限定はされないが、かかる範囲のpHに設定することによって、本発明を飲料として提供した際、より服用感が向上することが確認されている。   The pH of the beverage in the present invention is 2.0 to 7.0, more preferably 2.5 to 6.5 when chitosan is used. When using water-soluble chitosan, although it does not specifically limit, When providing this invention as a drink by setting to pH of this range, it has been confirmed that a feeling of taking improves more.

pHを上記範囲に保つために、必要に応じてpH調整剤を配合することができる。pH調整剤としては、クエン酸、リンゴ酸、フマル酸、酒石酸、乳酸、コハク酸等の有機酸及びそれらの塩類、塩酸などの鉱酸、水酸化ナトリウムなどの無機塩基等が挙げられる。   In order to keep the pH in the above range, a pH adjusting agent can be blended as necessary. Examples of the pH adjuster include organic acids such as citric acid, malic acid, fumaric acid, tartaric acid, lactic acid, and succinic acid, salts thereof, mineral acids such as hydrochloric acid, and inorganic bases such as sodium hydroxide.

本発明の飲料にはその他の成分として、ビタミン、ミネラル類、アミノ酸及びその塩類、生薬、生薬抽出物、カフェイン、ローヤルゼリー等を本発明の効果を損なわない範囲で適宜に配合することができる。さらに必要に応じて、抗酸化剤、着色剤、香料、矯味剤、界面活性剤、溶解補助剤、保存剤、甘味料等の添加物を本発明の効果を損なわない範囲で適宜に配合することができる。   In the beverage of the present invention, vitamins, minerals, amino acids and salts thereof, herbal medicines, herbal extracts, caffeine, royal jelly and the like can be appropriately blended as long as the effects of the present invention are not impaired. Furthermore, if necessary, additives such as antioxidants, colorants, fragrances, flavoring agents, surfactants, solubilizers, preservatives, sweeteners and the like are appropriately blended within a range not impairing the effects of the present invention. Can do.

本発明の飲料を調製する方法において、キトサンを用いる場合には、キトサンが中性付近では水に溶解しにくいため、溶液を一度酸性にする必要がある。キトサンを溶解させた酸性溶液は、後に中性に戻すこともでき、約pH7付近の飲料として調製することもできる。水溶性キトサンを用いる場合には、常法により調製することができ、その方法は特に限定されるものではなく、例えば、各成分を適量の精製水で溶解した後、pHを調整し、更に精製水を加えて容量調整し、必要に応じて濾過、滅菌処理を施す方法が挙げられ、本発明の飲料を得ることができる。   In the method for preparing a beverage of the present invention, when chitosan is used, it is difficult to dissolve in water near neutrality, so it is necessary to make the solution once acidic. The acidic solution in which chitosan is dissolved can be returned to neutrality later, and can be prepared as a beverage having a pH of about 7. When water-soluble chitosan is used, it can be prepared by a conventional method, and the method is not particularly limited. For example, after each component is dissolved in an appropriate amount of purified water, the pH is adjusted, and further purification is performed. A method of adjusting the volume by adding water and performing filtration and sterilization treatment as necessary can be obtained, and the beverage of the present invention can be obtained.

本発明の飲料は、ドリンク剤、シロップ等の医薬品及び医薬部外品の他、健康飲料、茶飲料、スポーツドリンク等の各種食品として提供することができる。   The beverage of the present invention can be provided as various foods such as health drinks, tea drinks, and sports drinks in addition to pharmaceuticals such as drinks and syrups and quasi drugs.

以下に実施例及び試験例を示し、本発明をより詳細に説明する。   The following examples and test examples illustrate the present invention in more detail.

本検討では水溶性キトサンとしてキトサンオリゴ糖(COS−YS)(焼津水産化学工業(株))を、キトサンとしてキトサン5(和光純薬(株))を用いた。
[試験液調製]
各試験液の処方は表1〜4に示す。
In this examination, chitosan oligosaccharide (COS-YS) (Yaizui Fisheries Chemical Co., Ltd.) was used as water-soluble chitosan, and chitosan 5 (Wako Pure Chemical Industries, Ltd.) was used as chitosan.
[Test solution preparation]
The formulations of each test solution are shown in Tables 1-4.

水溶性キトサンを配合する場合は、精製水に水溶性キトサンを溶かし、その溶液にコンドロイチン硫酸ナトリウム又は各多糖類を添加し、溶解させ、精製水を加えて全量100mLとし,塩酸及び水酸化カリウムでpHを調整した。   When blending water-soluble chitosan, dissolve water-soluble chitosan in purified water, add sodium chondroitin sulfate or each polysaccharide to the solution, dissolve it, add purified water to make a total volume of 100 mL, and add hydrochloric acid and potassium hydroxide. The pH was adjusted.

キトサンを配合する場合は、精製水にキトサンを添加して塩酸でpHを2以下とし、溶解させ,その溶液にコンドロイチン硫酸ナトリウムを添加、溶解させ,精製水を加えて全量100mLとし、水酸化カリウムでpHを調整した。   When chitosan is added, chitosan is added to purified water and adjusted to pH 2 or lower with hydrochloric acid, dissolved, sodium chondroitin sulfate is added to and dissolved in the solution, and purified water is added to make a total volume of 100 mL. The pH was adjusted with

pHを調整した各溶液をガラスビンに充填し、キャップを施して80℃-20分殺菌を行い、試験液を得た。
[官能試験方法(渋味の評価)]
沈殿が無く、飲料としての粘性に問題が無いと判断した試験液の渋味について、成人男女計5名からなるパネラーによる官能評価を行った。
Each solution with adjusted pH was filled in a glass bottle, capped, and sterilized at 80 ° C. for 20 minutes to obtain a test solution.
[Sensory test method (assessment of astringency)]
About the astringency of the test liquid which judged that there was no precipitation and there was no problem in the viscosity as a drink, sensory evaluation by the panel consisting of a total of five adult men and women was performed.

試験方法:各試験液約10mLを5秒間口に含んだ時に感じる渋味について、「非常に渋い」:5点、「とても渋い」:4点、「渋い」:3点、「少し渋い」:2点、「わずかに渋い」:1点、「何も感じない」:0点から選択させ、その平均点を用いて評価した。なお、官能評価は各表毎に行い、表中の各試験液の官能評価は30分以上の間隔をおいて実施した。
[結果]
(1)コンドロイチン硫酸の効果(pH4.5)
水溶性キトサンとコンドロイチン硫酸ナトリウム(生化学工業(株))を配合し、pHを4.5に調整した処方を実施例1とした。実施例1からコンドロイチン硫酸ナトリウムを抜いた処方を比較例1、コンドロイチン硫酸ナトリウムの代わりに同じ多糖類であるデキストリン(和光純薬(株))、アルギン酸ナトリウム(和光純薬(株))、ペクチン(和光純薬(株))、λ-カラギーナン(和光純薬(株))、を配合した処方を比較例2〜5とした。実施例1及び比較例1の水溶性キトサンをキトサンに置き換えたものを実施例5及び比較例9とした。各処方と、各試験液調製直後の目視による沈殿の有無及び飲料としての粘性の適否、並びに官能試験の結果を表1に記載した。
Test method: About 10 ml of each test solution in the mouth for 5 seconds, “very astringent”: 5 points, “very astringent”: 4 points, “astringent”: 3 points, “a little astringent”: 2 points, “slightly astringent”: 1 point, “I don't feel anything”: 0 points were selected and evaluated using the average score. The sensory evaluation was performed for each table, and the sensory evaluation of each test solution in the table was performed at intervals of 30 minutes or more.
[result]
(1) Effect of chondroitin sulfate (pH 4.5)
A formulation in which water-soluble chitosan and chondroitin sulfate sodium (Seikagaku Corporation) were blended and the pH was adjusted to 4.5 was named Example 1. A formulation obtained by removing sodium chondroitin sulfate from Example 1 is Comparative Example 1, dextrin (Wako Pure Chemical Industries, Ltd.), sodium alginate (Wako Pure Chemical Industries, Ltd.), pectin (same polysaccharide instead of sodium chondroitin sulfate). Comparative examples 2 to 5 were prepared by blending Wako Pure Chemical Industries, Ltd.) and λ-carrageenan (Wako Pure Chemical Industries, Ltd.). Examples 5 and 9 were obtained by replacing the water-soluble chitosan of Example 1 and Comparative Example 1 with chitosan. Table 1 shows each formulation, the presence or absence of visual precipitation immediately after preparation of each test solution, the suitability of viscosity as a beverage, and the results of a sensory test.

Figure 0004840298
実施例及び比較例の評価を行った結果、比較例3は粘度が非常に高く、また比較例4及び5のサンプルは沈殿が生じたため、飲料としては適していなかった。
Figure 0004840298
As a result of evaluating Examples and Comparative Examples, Comparative Example 3 was very high in viscosity, and the samples of Comparative Examples 4 and 5 were not suitable as beverages because precipitation occurred.

官能評価値より水溶性キトサン又はキトサン配合溶液にコンドロイチン硫酸を添加することで、比較例1、2及び9で認められている渋味が良好に改善されていることがわかった。
(2)水溶性キトサンの渋味に対するコンドロイチン硫酸とpHの影響
実施例1のpHを2.5及び6.5に調整したものを各々実施例2及び3とし、実施例2及び3からコンドロイチン硫酸ナトリウムを抜いた処方を各々比較例6及び7とした。
From the sensory evaluation value, it was found that the astringency recognized in Comparative Examples 1, 2, and 9 was improved satisfactorily by adding chondroitin sulfate to the water-soluble chitosan or chitosan-containing solution.
(2) Effect of chondroitin sulfate and pH on astringent taste of water-soluble chitosan Example 2 and 3 were prepared by adjusting the pH of Example 1 to 2.5 and 6.5, respectively. The formulations from which sodium was removed were referred to as Comparative Examples 6 and 7, respectively.

Figure 0004840298
水溶性キトサンはpHが低いほど渋味が強いが、水溶性キトサン配合溶液にコンドロイチン硫酸を添加することで、比較例6、1及び7でそれぞれ認められている水溶性キトサンの渋味が各pHで良好に改善されていることがわかった。
(3)キトサンの渋味に対するコンドロイチン硫酸とpHの影響
表2における実施例1〜3並びに比較例1、6及び7の水溶性キトサンを、キトサンに置き換えたものを実施例4〜6及び比較例8〜10とした。
Figure 0004840298
Although the water-soluble chitosan has a stronger astringency as the pH is lower, by adding chondroitin sulfate to the water-soluble chitosan-containing solution, the astringency of the water-soluble chitosan recognized in Comparative Examples 6, 1 and 7 respectively is It was found that the improvement was good.
(3) Effects of chondroitin sulfate and pH on astringent taste of chitosan Examples 4 to 6 and comparative examples in which the water-soluble chitosan in Examples 1 to 3 and Comparative Examples 1, 6 and 7 in Table 2 were replaced with chitosan 8-10.

Figure 0004840298
キトサンはpHが低いほど渋味が強いが、キトサン配合溶液にコンドロイチン硫酸を添加することで、比較例8〜10でそれぞれ認められているキトサンの渋味が各pHで良好に改善されていることがわかった。
(4)水溶性キトサンの渋味に対するコンドロイチン硫酸配合量の影響
実施例1から水溶性キトサンとコンドロイチン硫酸ナトリウムの配合比を変化させたものを実施例7〜11及び比較例11とした。
Figure 0004840298
Chitosan has a stronger astringency as the pH is lower, but by adding chondroitin sulfate to the chitosan formulation solution, the astringency of chitosan recognized in Comparative Examples 8 to 10 is improved at each pH. I understood.
(4) Effect of blending amount of chondroitin sulfate on astringency of water-soluble chitosan Examples 7 to 11 and Comparative Example 11 were prepared by changing the blending ratio of water-soluble chitosan and chondroitin sulfate from Example 1.

Figure 0004840298
水溶性キトサン配合溶液に、水溶性キトサンの0.1重量部以上のコンドロイチン硫酸ナトリウムを配合することで渋味がマスキングされ、1重量部以上のコンドロイチン硫酸ナトリウムを配合することで渋味がほとんど無くなることがわかった。
Figure 0004840298
Astringency is masked by blending 0.1 part by weight or more of sodium chondroitin sulfate with water-soluble chitosan blended solution, and astringency is almost eliminated by blending 1 part by weight or more of sodium chondroitin sulfate. I understood it.

以上のように、水溶性キトサン又はキトサン配合溶液にコンドロイチン硫酸ナトリウムを配合することで、水溶性キトサン又はキトサンに起因する渋みを優位に抑制し、且つ飲料に適した粘性を有する溶液の調製ができることがわかった。   As described above, by blending sodium chondroitin sulfate with water-soluble chitosan or chitosan-containing solution, it is possible to preferentially suppress astringency caused by water-soluble chitosan or chitosan and to prepare a solution having viscosity suitable for beverages I understood.

本発明により、キトサンにより生じる渋味が改善された、極めて服用しやすい飲料を、医薬品及び医薬部外品並びに食品領域の飲料として提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the drink which is very easy to take with the astringent taste which arises by chitosan can be provided as a drink of a pharmaceutical, a quasi-drug, and a food area | region.

Claims (3)

キトサン、及びキトサン1質量部に対して1〜20質量部のコンドロイチン硫酸又はその塩を配合し、pHが2.0〜7.0であることを特徴とする飲料。 A beverage comprising 1 to 20 parts by mass of chondroitin sulfate or a salt thereof per 1 part by mass of chitosan and having a pH of 2.0 to 7.0 . キトサンが、水溶性キトサンである請求項1記載の飲料。 The beverage according to claim 1, wherein the chitosan is water-soluble chitosan. 水溶性キトサンが、キトサンオリゴ糖である請求項記載の飲料。 The beverage according to claim 2 , wherein the water-soluble chitosan is chitosan oligosaccharide.
JP2007228408A 2007-09-04 2007-09-04 Chitosan combination beverage Active JP4840298B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007228408A JP4840298B2 (en) 2007-09-04 2007-09-04 Chitosan combination beverage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007228408A JP4840298B2 (en) 2007-09-04 2007-09-04 Chitosan combination beverage

Publications (2)

Publication Number Publication Date
JP2009055882A JP2009055882A (en) 2009-03-19
JP4840298B2 true JP4840298B2 (en) 2011-12-21

Family

ID=40552215

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007228408A Active JP4840298B2 (en) 2007-09-04 2007-09-04 Chitosan combination beverage

Country Status (1)

Country Link
JP (1) JP4840298B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6085875B2 (en) * 2013-03-29 2017-03-01 地方独立行政法人鳥取県産業技術センター Recuperation restraint 柿 puree for heating
JP6924134B2 (en) * 2017-12-27 2021-08-25 サントリーホールディングス株式会社 Non-fermented or semi-fermented tea beverages containing chitosan
CN108157971A (en) * 2018-02-08 2018-06-15 沈勇子 A kind of chitosan oligosaccharide liquid oral medicine and preparation method thereof
JP7182432B2 (en) 2018-11-14 2022-12-02 サントリーホールディングス株式会社 Beverage containing chitosan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3770518B2 (en) * 1997-03-28 2006-04-26 エーザイ株式会社 Oral drugs concealing bitterness
FR2791262B1 (en) * 1999-03-22 2001-09-28 Virbac Sa COMPOSITIONS BASED ON CHONDROITINE AND CHITOSAN FOR THE PROTECTION, TREATMENT OR REPLACEMENT OF CONNECTIVE TISSUES
JP2002003379A (en) * 2000-06-23 2002-01-09 Taisho Pharmaceut Co Ltd Vitamin b1 derivative-formulated composition
JP4414153B2 (en) * 2003-04-07 2010-02-10 三井農林株式会社 How to prevent turbidity of acidic tea beverages
JP2006191830A (en) * 2005-01-12 2006-07-27 Unitika Ltd Food for suppressing fat accumulation

Also Published As

Publication number Publication date
JP2009055882A (en) 2009-03-19

Similar Documents

Publication Publication Date Title
KR101852555B1 (en) Composition for syrup containing allulose and food comprising the composition
TWI235660B (en) Drugs against articular failure
JP5184257B2 (en) Beverages containing eggshell membrane powder
JP4248653B2 (en) Easily swallowing assist composition, food composition and pharmaceutical composition using the same
JP4263513B2 (en) Mastication / swallowing foods and chewing / swallowing assist compositions
JPWO2005034938A1 (en) Collagen production enhancer, its production method and use
JP4652486B2 (en) Formulation for oral administration containing chondroitin sulfate-containing cartilage aqueous solvent extract and quercetin glycoside
KR20090115936A (en) Diet product comprising alginate
JP4840298B2 (en) Chitosan combination beverage
CN110960497B (en) Hyaluronic acid buccal tablet and preparation method thereof
JP2004350680A (en) Gelling agent composition and gelatinous composition for food suitable for person with ingestion/swallowing difficulty
JP6285497B2 (en) Oral composition containing chicken crown extract and method for improving ingestion difficulty derived from flavor of chicken crown extract
JPH02248401A (en) Low-molecular guar gum, its production and food and drink containing same
JP4843837B2 (en) Thiamine derivative-containing composition
JP2007099653A (en) Arthrodynia ameliorator
JP5151083B2 (en) Oral composition
JP6566581B2 (en) Ceramide-containing composition with excellent stability
JP2002034505A (en) Food composition formulated with silymarin
JP4981327B2 (en) UV absorber
CN113973948B (en) Preparation method of color-changeable hyaluronic acid beverage
JP4992162B2 (en) Oral solution containing iron ions
JP4131770B2 (en) healthy food
KR20200032482A (en) Bitter taste improvement composition
JP6802627B2 (en) Leucine bitterness reducing agent and leucine bitterness reducing method
JP3944116B2 (en) Iron odor control agent

Legal Events

Date Code Title Description
RD07 Notification of extinguishment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7427

Effective date: 20090624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100601

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110906

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110919

R150 Certificate of patent or registration of utility model

Ref document number: 4840298

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141014

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141014

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250